Skip to NavigationSkip to content

News

A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in combination with the steroid...
Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration (nAMD...
Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to information from the Centers...
Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or more combo therapies for the...
US Health and Human Services (HHS) Secretary Alex Azar responded to industry criticism on Friday after big pharma warned that Trump’s initiative,...
Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an...
Check out the Top Ten most popular articles on Pharmafile.com this week!
India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new...
It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health and Care Excellence (NICE...
The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy designation...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches